CHARLESSON, LLP

Basic Information

800 Research Parkway
OKLAHOMA CITY, OK, 73104-3611

Company Profile

n/a

Additional Details

Field Value
DUNS: 143171531
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 10


  1. A Novel Therapeutic Antibody for Age-related Macular Degeneration

    Amount: $225,000.00

    DESCRIPTION provided by applicant Age related macular degeneration AMD is a common disease of the central retina and remains a leading cause of vision loss and blindness in elderly Americans Cur ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  2. Developing A Novel Therapy for Diabetic Retinopathy

    Amount: $785,308.00

    DESCRIPTION provided by applicant Diabetic retinopathy DR is a common complication of diabetes and a leading cause of vision loss in the United States Although the anti vascular endothelial grow ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  3. A Wnt Modulator for Treatment of Age-related Macular Degeneration

    Amount: $225,000.00

    PROJECT SUMMARY/ABSTRACT Age-related macular degeneration (AMD) is characterized by progressively decreased central vision and visual acuity and remains a leading cause of vision loss and blindness i ...

    SBIR Phase I 2014 Department of Health and Human Services
  4. Developing A Novel Therapy for Diabetic Retinopathy

    Amount: $246,418.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of vision loss in the United States. Unfortunately, there is no FDA-approved pha ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. A Small Molecule Targeting Wnt Pathway for Treatment of Diabetic Retinopathy

    Amount: $231,087.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of blindness. This sight-threatening condition has become a public health challe ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Multitargeted Therapy for Age-related Macular Degeneration

    Amount: $265,992.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is a sight-threatening disease which represents the leading cause of blindness and visual impairment in elderly individu ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Novel emulsion-based formulation of the anti-glaucoma MSH-1001 for improved topic

    Amount: $287,947.00

    DESCRIPTION (provided by applicant): This Small Business Innovation project aims to develop an innovative eye drop formulation for the treatment of glaucoma and ocular hypertension. Charlesson has acq ...

    SBIR Phase I 2011 Department of Health and Human Services
  8. Safety and Toxicology Studies of CLT-005 as a Therapeutic for Diabetic Macular Ed

    Amount: $2,685,795.00

    DESCRIPTION (provided by applicant): The objective of this proposal is to finalize development of CLT-005, a novel small molecule inhibitor of Stat3, through the performance of studies required fo ...

    SBIR Phase II 2011 Department of Health and Human Services
  9. Novel Antioxidants for Treatment of Diabetic Retinopathy

    Amount: $248,094.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy is a common complication of diabetes mellitus and a leading cause of severe vision loss and blindness around the world. The current interventi ...

    SBIR Phase I 2009 Department of Health and Human Services
  10. Development of a novel anti-inflammatory treatment for clinical management of end

    Amount: $227,286.00

    DESCRIPTION (provided by applicant): The objective of this proposal is to examine the efficacy of CLT-005 in reducing ocular inflammation and that occurs during endophthalmitis. Endophthalmitis occurs ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government